Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson’s Disease: Implications for Gut Microbiota and PGC-1α

26 Feb 2024

Abstract excerpt

Intestinal dysbiosis plays a critical role in the pathogenesis of Parkinson's disease (PD), and probiotics have emerged as potential modulators of central nervous system function through the microbiota-gut-brain axis. This study aimed to elucidate the anti-inflammatory effects and underlying mechanisms of the probiotic strain Bifidobacterium animalis subsp. lactis NJ241 (NJ241) in a mouse model of PD induced by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38409641
DOI: 10.1007/s12035-024-04038-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson’s Disease: Implications for Gut Microbiota and PGC-1αPMID 38409641Read ↗

Supplementation with Bifidobacterium animalis subsp. lactis MH-022 for remission of motor impairments in a 6-OHDA-induced Parkinson's disease rat model by reducing inflammation, reshaping the gut microbiome, and fostering specific microbial taxaSemantic proximity Read ↗

Impact of Nutrition on the Gut Microbiota: Implications for Parkinson’s DiseaseSemantic proximity Read ↗

Gut-Brain Axis and Parkinson's Disease: The Role of Small Intestinal Microbiota from Symptom Onset to Therapeutic PerspectivesSemantic proximity Read ↗

Modulation of Behavioral, Biochemical, Immunomodulatory, and Transcriptional Profiles by the Strain <em>Limosilactobacillus fermentum</em> U-21 in Combined Model of Parkinson’s Disease in Rats <em>Wistar</em>Semantic proximity Read ↗

A review of studies on gut microbiota and levodopa metabolismSemantic proximity Read ↗

Neuroprotective effect of engineered Clostridium butyricum‐pMTL007‐GLP ‐1 on Parkinson's disease mice models via promoting mitophagySemantic proximity Read ↗

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain AxisSemantic proximity Read ↗

Probiotics for Neurodegenerative Diseases: A Systemic ReviewSemantic proximity Read ↗

Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson’s DiseaseSemantic proximity Read ↗

Next Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic PerspectiveSemantic proximity Read ↗

Unveiling the Synapses: Gut Microbiota and Neurodegenerative Disorders Through the Gut–Brain AxisSemantic proximity Read ↗

Wu Mei Pill Mitigates Dopaminergic Neuron Damage-Induced Parkinson's Disease in Mice Through Modulation of the Gut-Brain-Microbiota AxisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.